Pharmaceuticals

Amylyx Pharmaceuticals (NASDAQ: AMLX) stock is rising in after-hours trading on FDA approval of its ALS drug.

Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable...

Biopharmaceutical outfit Ardelyx Inc (NASDAQ: ARDX) has recently started selling its first treatment, but is ARDX stock worth backing?

Regen BioPharma recently filed a patent related to a mRNA cancer immunotherapeutic vaccine. Does the market growth potential make RGBP a good...

Here we take a look at Atai Life Sciences stock and examine whether the company's stock of alternative and psychedelic treatment candidates makes...

Eton Pharmaceuticals (NASDAQ: ETON) saw its stock price rise this morning following FDA approval for its epilepsy treatment. But is the stock a...

Pliant Therapeutics saw its share price more than double first thing on Monday after reporting positive feedback from trials of its pulmonary...

Veru Inc (NASDAQ: VERU) is buoyant following a strong showing from its COVID-19 treatment in a recent study, which excited investors having taken...

Birth control specialist Evofem Biosciences has seen its share price rocket after the highest court in the US announced the reversal of abortion...

Annually, more than 550k new cases of heart failure are diagnosed in the United States. That's why Cardiol Therapeutics (NASDAQ: CRDL) is...

We break down and analyse the IPO of bioAffinity Technologies, a cancer testing specialist poised to join the NASDAQ index next week.

Tuesday's trending stocks include the likes of Yamana Gold (NYSE: AUY), Mullen Automotive (NASDAQ: MULN) and TherapeuticsMD (NASDAQ: TXMD).

Comera Life Sciences Holdings (NASDAQ: CMRA) $159m IPO. 

We're discussing diabetes and heart failure with reference to Eli Lilly & Co. (NYSE: LLY), Novo Nordisk (NYSE: NVO), Sanofi (NASDAQ: SNY) and...

Bausch + Lomb is about to go public with an IPO, so we're taking a look at the stock to see if there's a clear case for investing.

Algernon Pharma (CSE: AGN, FRANKFURT: AGWO, OTCQB: AGNPF) plans to list on the NASDAQ Capital Market in an IPO.